ArticleNature communications2022

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2.

Eduardo Hermosilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.